
Desvenlafaxine
Active ingredients · Desvenlafaxine Succinate
100 mg/1 · Extended-Release Tablet
By Slate Run Pharmaceuticals, LLC
- NDC
- 70436-013
- Route
- Oral
- Therapeutic class
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor
- Marketing category
- ANDA
Package sizes
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-013-04)NDC 70436-013-04Available to order
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-013-06)NDC 70436-013-06Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

